title: Effect of alfacalcidol on renal bone disease in mild to moderate renal failure. Questions remain over alfacalcidol's efficacy in preventing secondary hyperparathyroidism.
authors.forename: A
authors.initials: A
authors.lastname: Fournier
authors.forename: N E
authors.initials: NE
authors.lastname: Esper
authors.forename: P
authors.initials: P
authors.lastname: Moriniere
authors.forename: R
authors.initials: R
authors.lastname: Oprisiu
authors.forename: A
authors.initials: A
authors.lastname: Marie
mesh_terms: D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy*; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D006962:Hyperparathyroidism, Secondary / Q000517:prevention & control*; D007676:Kidney Failure, Chronic / Q000150:complications*
chemical_list: D006887:Hydroxycholecalciferols; C008088:alfacalcidol